%0 Journal Article %A Ben Edwards %A Nicholas Biddle %A Matthew Gray %A Kate Sollis %T COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population %D 2020 %R 10.1101/2020.11.13.20231480 %J medRxiv %P 2020.11.13.20231480 %X High levels of vaccination coverage in populations will be required even with vaccines have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy ‘hotspots’ based on social and behavioural insights and this paper provides the first representative longitudinal survey of over 3000 participants from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine.We distinguish between those who may get the vaccine but are not sure (hesitant) from those who will definitely get the vaccine because they are usually a large percentage of the population, and are more likely to be convinced about public health messaging and information about vaccine safety. We find that 59 per cent of Australians say that they will definitely get the vaccine, a further 29 per cent were likely to get the vaccine but are not certain (low levels of hesitancy), 7 per cent will probably not get the vaccine (high levels of hesitancy) and 6 per cent will definitely not get the vaccine (resistant).We find that females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated. Our findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but that for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Australian Institute of Health and Welfare (AIHW) provided financial support for the analysis of the August ANUpoll data presented in this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethical aspects of this study have been approved by the ANU Human Research Ethics Committee (2014/241).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available through the Australian Data Archive. https://dataverse.ada.edu.au/dataset.xhtml?persistentId=doi:10.26193/GG2GE3 https://dataverse.ada.edu.au/dataset.xhtml?persistentId=doi:10.26193/HLMZNW https://dataverse.ada.edu.au/dataset.xhtml?persistentId=doi:10.26193/GNEHCQ https://dataverse.ada.edu.au/dataset.xhtml?persistentId=doi:10.26193/ZFGFNE %U https://www.medrxiv.org/content/medrxiv/early/2020/11/16/2020.11.13.20231480.full.pdf